Sucralfate
NDC 43353-061
Product Information
Sucralfate is a NDA-approved product labeled by Aphena Pharma Solutions - Tennessee, Llc. This medication is used to treat and prevent ulcers in the intestines. It is supplied as a blue product. This product entry covers the primary NDC 43353-061 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
WATSON;780
Code Structure Chart
Product Details
What is NDC 43353-061?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SUCRALFATE (UNII: XX73205DH5)
- SUCRALFATE (UNII: XX73205DH5) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- STARCH, CORN (UNII: O8232NY3SJ)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 314234 - sucralfate 1 GM Oral Tablet
- RxCUI: 314234 - sucralfate 1000 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.
Patient Education
Sucralfate
Sucralfate is used to treat and prevent the return of duodenal ulcers (ulcers located in first part of the small intestine). Treatment with other medications, such as antibiotics, may also be necessary to treat and prevent the return of ulcers caused by a certain type of bacteria (H. pylori) Sucralfate is in a class of medications called protectants. It sticks to damaged ulcer tissue and protects against acid and enzymes so healing can occur.
[Learn More]
* Please review the full disclaimer at the bottom of this page.